HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
Viruses · 19.07.2024 · 16 (7) · 1163
DOI: 10.3390/v16071163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 19.07.2024. Verfasst von Tessa C Chou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, CA 92617, USA. Hauptthemen laut MEDLINE: Virus Latency, HIV Infections, HIV-1. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institute of Health.
Abstract (Originalsprache)
The latent reservoir remains a major roadblock to curing human immunodeficiency virus (HIV) infection. Currently available antiretroviral therapy (ART) can suppress active HIV replication, reduce viral loads to undetectable levels, and halt disease progression. However, antiretroviral drugs are unable to target cells that are latently infected with HIV, which can seed viral rebound if ART is stopped. Consequently, a major focus of the field is to study the latent viral reservoir and develop safe and effective methods to eliminate it. Here, we provide an overview of the major mechanisms governing the establishment and maintenance of HIV latency, the key challenges posed by latent reservoirs, small animal models utilized to study HIV latency, and contemporary cure approaches. We also discuss ongoing efforts to apply these approaches in combination, with the goal of achieving a safe, effective, and scalable cure for HIV that can be extended to the tens of millions of people with HIV worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, CA 92617, USA.
- Department of Medicine, Division of Infectious Disease, School of Medicine, University of California, Irvine, CA 92617, USA.
ORCID-Profile: Tessa C Chou, Nishad S Maggirwar, Matthew D Marsden
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institute of Health
Zitieren
APA
Chou, T. C., Maggirwar, N. S., & Marsden, M. D. (2024). HIV Persistence, Latency, and Cure Approaches: Where Are We Now?. Viruses, 16(7), 1163. https://doi.org/10.3390/v16071163
Vancouver
Chou TC, Maggirwar NS, Marsden MD. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?. Viruses. 2024;16(7):1163. doi:10.3390/v16071163
BibTeX
@article{Chou2024,
author = {Chou, Tessa C and Maggirwar, Nishad S and Marsden, Matthew D},
title = {HIV Persistence, Latency, and Cure Approaches: Where Are We Now?},
journal = {Viruses},
year = {2024},
volume = {16},
number = {7},
pages = {1163},
doi = {10.3390/v16071163}
}
EUVIMED